Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sept 18 (Reuters) — SANDOZ GROUP AG: Sandoz Receives Regulatory Approval For Generic Semaglutide In Canada, Paving Way To Expand Patient Access To Key Glp-1 Medicine Receives Regulatory Approval For Generic Semaglutide In Canada Health Canada Grants Marketing Authorisation For Sandoz Semaglutide Semaglutide Approved In
Sandoz Group (D8Y) said it has received Canada approval for its generic semaglutide.
Sandoz Group AG / Key word(s): Regulatory Approval Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine 18-Sep-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of th